← The Wire
WVENasdaq
Wave Life Sciences Ltd.
Pharmaceutical Preparations · U0 · CIK 1631574
Wave Life Sciences develops RNA medicines to treat rare and common disorders by targeting RNA with innovative chemistry
$1.13B
Market cap
$5.68
Last close
-2.6%
1D
-7.9%
5D
2.7M
Volume
Price · last 39 sessions-24.0%
May 4L $5.66 · H $7.47Jun 29
273
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 26, 20268-KReg FD Disclosure · Company UpdateMay 18, 2026DEF 14ADEF 14AMay 7, 202610-K/A10-K/AApr 30, 202610-Q10-QApr 28, 20268-KResults of Operations · Reg FD DisclosureApr 28, 2026DEFA14ADEFA14AApr 21, 20268-KCompany UpdateApr 21, 2026SC 13D/ASC 13D/AApr 17, 2026DEFA14ADEFA14AApr 15, 20268-KMaterial Agreement · Company UpdateApr 15, 2026SC 13D/ASC 13D/AMar 30, 20268-KReg FD Disclosure · Company UpdateMar 26, 202610-K10-KFeb 26, 20268-KResults of Operations · Reg FD DisclosureFeb 26, 20268-KCompany UpdateFeb 2, 20268-KResults of Operations · Reg FD DisclosureJan 12, 2026SC 13D/ASC 13D/ADec 15, 2025424B5424B5Dec 11, 20258-KMaterial Agreement · Reg FD DisclosureDec 11, 2025424B5424B5Dec 8, 20258-KReg FD Disclosure · Company UpdateDec 8, 20258-KReg FD DisclosureNov 17, 202510-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-K/AReg FD Disclosure · Company UpdateOct 30, 20258-KReg FD Disclosure · Company UpdateOct 29, 20258-KReg FD DisclosureSep 24, 20258-KReg FD Disclosure · Company UpdateSep 3, 20258-KExecutive Change · Shareholder VoteAug 11, 20258-KReg FD DisclosureAug 5, 202510-Q10-QJul 30, 20258-KResults of OperationsJul 30, 2025DEF 14ADEF 14AJun 23, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 8, 202510-K/A10-K/AApr 29, 20258-KReg FD Disclosure · Company UpdateMar 26, 202510-K10-KMar 4, 20258-KResults of Operations · Reg FD DisclosureMar 4, 20258-KReg FD DisclosureJan 13, 20258-KReg FD DisclosureNov 20, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 2024SC 13GSC 13GNov 8, 20248-KReg FD Disclosure · Company UpdateOct 30, 2024SC 13GSC 13GOct 18, 20248-KReg FD Disclosure · Company UpdateOct 16, 20248-KReg FD Disclosure · Company UpdateOct 15, 20248-KReg FD DisclosureOct 1, 2024424B5424B5Sep 27, 20248-KMaterial Agreement · Reg FD DisclosureSep 26, 2024424B5424B5Sep 24, 20248-KReg FD Disclosure · Company UpdateSep 24, 20248-KExecutive Change · Shareholder VoteAug 12, 202410-Q10-QAug 8, 20248-KResults of Operations · Reg FD DisclosureAug 8, 20248-KReg FD Disclosure · Company UpdateJun 25, 2024DEF 14ADEF 14AJun 21, 202410-Q10-QMay 10, 20248-KResults of Operations · Reg FD DisclosureMay 9, 202410-K/A10-K/AApr 29, 202410-K10-KMar 6, 20248-KResults of Operations · Reg FD DisclosureMar 6, 20248-KReg FD DisclosureJan 8, 20248-KCompany UpdateJan 4, 20248-KReg FD DisclosureDec 15, 2023424B5424B5Dec 8, 20238-KMaterial Agreement · Reg FD DisclosureDec 8, 2023424B5424B5Dec 6, 20238-KReg FD DisclosureNov 9, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KReg FD DisclosureOct 2, 20238-KReg FD Disclosure · Company UpdateSep 28, 20238-KReg FD DisclosureSep 5, 20238-KExecutive Change · Shareholder VoteAug 7, 202310-Q10-QAug 3, 20238-KResults of Operations · Reg FD DisclosureAug 3, 2023DEF 14ADEF 14AJun 26, 2023
Insider Activity
In the 90 days to Mar 30, 2026: 1 insider bought $54.6M · 4 sold $908K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 971,091 | $6.50 | $6.3M |
| Mar 27, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 2,495,623 | $6.43 | $16.0M |
| Mar 26, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 4,954,558 | $6.06 | $30.0M |
| Mar 26, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 351,224 | $6.38 | $2.2M |
| Feb 26, 2026 | Francis ChrisSee Remarks | Sell | 17,900 | $15.09 | $270K |
| Feb 26, 2026 | Francis ChrisSee Remarks | Sell | 15,294 | $15.00 | $229K |
| Feb 9, 2026 | Bolno PaulPresident and CEO | Sell | 10,480 | $13.45 | $141K |
| Feb 9, 2026 | Moran KyleChief Financial Officer | Sell | 3,588 | $13.45 | $48K |
| Feb 9, 2026 | Vargeese ChandraSee Remarks | Sell | 3,228 | $13.45 | $43K |
| Feb 9, 2026 | Francis ChrisSee Remarks | Sell | 1,883 | $13.45 | $25K |
| Jan 2, 2026 | Francis ChrisSee Remarks | Sell | 8,080 | $15.92 | $129K |
| Jan 2, 2026 | Francis ChrisSee Remarks | Sell | 1,295 | $16.70 | $22K |
| Dec 11, 2025 | Gsk PlcTenPercentOwner | Buy | 1,470,000 | $19.00 | $27.9M |
| Dec 9, 2025 | Moran KyleChief Financial Officer | Sell | 50,000 | $20.03 | $1.0M |
| Dec 9, 2025 | Moran KyleChief Financial Officer | Sell | 36 | $20.25 | $729 |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 122,349 | $14.20 | $1.7M |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 107,400 | $14.56 | $1.6M |
| Dec 8, 2025 | Moran KyleChief Financial Officer | Sell | 50,000 | $18.00 | $900K |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 50,000 | $16.00 | $800K |
| Dec 8, 2025 | Moran KyleChief Financial Officer | Sell | 60,000 | $13.20 | $792K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance